BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for systemic lupus erythematosus (SLE) to its discovery portfolio through its collaboration with BenevolentAI.
Second target to be selected this year from the extended collaboration with AstraZeneca, highlighting continued...
Life Sciences BC (LSBC) is pleased to announce the recipients of the 26th Annual Life Sciences BC Awards presented by Farris. These awards recognize the exceptional achievements of individuals, companies, and organizations across British Columbia’s life sciences sector that have successfully advanced health innovations and significantly enriched our dynamic...
Superbio AI, Inc., announced that it has entered into an initiative with Memorial Sloan Kettering Cancer Center (MSK) to make user-friendly biomedical AI available for providers, researchers, and drug developers working to advance the standard of care.
Under this initative, Superbio AI’s proprietary software platform will be utilized to deploy...
Rower Consulting, a trailblazer in cutting-edge analytics and artificial intelligence (AI) solutions, is pleased to announce a dynamic partnership with Dataiku, a pioneering force in Everyday AI. This collaboration marks a leap forward in Rower Consulting's mission to empower the pharmaceutical and other verticals with enhanced real-time analytics and strategic...
Scientist.com, the world's leading marketplace for biopharmaceutical research, announced the launch of a new Large Language Model (LLM)-powered research assistant called Elisa, named in reference to a widely used research test and ELIZA, a chatbot of the early 1960s. Elisa is the latest addition to a suite of proprietary...
Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the leader in artificial intelligence (AI)-powered cancer diagnostics, announced the launch of the Ibex’s AI platform in routine practice within Alverno’s laboratory network in...
Athos accelerates the development of precision therapeutics for patients with immune-mediated diseases and cancer by scaling its autonomous AI analytical platform
Vultr, the world’s largest, privately-held cloud computing platform, announced that Athos Therapeutics, Inc., a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning,...
Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the United States Food and Drug Administration (FDA). The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides to help diagnose...
Certara, Inc., a global leader in model-informed drug development, unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers. It combines generative AI, document templates, Microsoft Word integration, and structured content authoring tools. CoAuthor accelerates the creation of regulatory documents while maintaining a...
At HLTH Europe, the Trustworthy & Responsible AI Network (TRAIN), a consortium of healthcare leaders, announced its expansion to Europe with the objective to help organizations in the region operationalize responsible AI through technology-based guardrails. Organizations that have come together to form the European TRAIN include Erasmus MC (the Netherlands), HUS Helsinki...
